SCHEMBL4789960

SCHEMBL4789960

NC(=O)c1cccc(Oc2ccccc2)c1-c1cccnc1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CTNNB1 P35222 1/20 0.56
ALDH1A1 P00352 2/20 0.52
MAPK1 P28482 1/20 0.52
HSD17B10 Q99714 1/20 0.52
MKNK1 Q9BUB5 10/20 0.47
MKNK2 Q9HBH9 9/20 0.47
PKN1 Q16512 1/20 0.45
PKN2 Q16513 1/20 0.45
BRD4 O60885 1/20 0.45
LMNA P02545 1/20 0.44
JAK2 O60674 1/20 0.43
JAK3 P52333 1/20 0.43
PARP1 P09874 1/20 0.43
DHODH Q02127 1/20 0.43
PARP2 Q9UGN5 1/20 0.43
KDM4C Q9H3R0 1/20 0.43
MAPK8 P45983 1/20 0.42
MAPK10 P53779 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30343294 0.83 MKNK1 (0.64) MKNK1MKNK2PKN1PKN2PARP1
SCHEMBL27880990 0.82 MKNK1 (0.58) ALDH1A1MKNK1MKNK2PKN1PKN2
SCHEMBL4789958 0.81 CTNNB1 (0.47) CTNNB1ALDH1A1MAPK1HSD17B10MKNK1
SCHEMBL28131715 0.81 ALDH1A1 (0.47) CTNNB1ALDH1A1MAPK1HSD17B10MKNK1
SCHEMBL8809860 0.80 BCAT2 (0.56) MKNK1MKNK2PKN1PKN2JAK2
SCHEMBL1702138 0.79 CTNNB1 (0.68) CTNNB1ALDH1A1MAPK1HSD17B10MKNK1
SCHEMBL30060692 0.79 CTNNB1 (0.68) CTNNB1ALDH1A1MAPK1HSD17B10MKNK1
SCHEMBL17591715 0.78 MKNK1 (0.54) MKNK1MKNK2PKN1PKN2JAK2
SCHEMBL30410982 0.78 MKNK1 (0.54) MKNK1MKNK2PKN1PKN2JAK2
SCHEMBL3717532 0.77 CA12 (0.47) ALDH1A1MAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1957073-A2 MEDICINAL DRUG OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-08-20 EP disclosed
WO-2007066784-A2 DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-06-14 WO disclosed